Pharmafile Logo

Genesis Research Group announces inaugural membership of ISPOR Corporate Partnership Program

Genesis Research Group, a pioneer of tech-enabled real-world evidence (RWE), health economics and outcomes research (HEOR), and market access services, today announces it has joined selected organizations as an inaugural member of ISPOR—The Professional Society for Health Economics and Outcomes Research’s Corporate Partnership Program. This strategic alliance with ISPOR reinforces Genesis Research Group’s commitment to advancing HEOR to inform healthcare decision-making and improve patient access to life-changing therapies.

ISPOR partner seal

As a member of ISPOR’s Corporate Partnership Program, Genesis Research Group will collaborate with ISPOR and the global HEOR community to support initiatives that advance and strengthen HEOR, in alignment with ISPOR’s Strategic Plan 2030. This includes cutting edge research, education and training, and enhancing health outcomes research through evidence-based practices throughout the wider healthcare industry.

“We are very excited to launch the new Corporate Partner Program, welcome Genesis Research Group, and invite them and other organizations to contribute to ISPOR’s vision of a world where healthcare is accessible, effective, efficient, and affordable for all,” commented Rob Abbott, CEO of ISPOR. “Organizations who become ISPOR Corporate Partners will take an active role in the Society’s mission to improve healthcare decisions and achieving this vision, while elevating their presence with key stakeholders.”

“The importance of leveraging HEOR to inform healthcare decision-making has never been greater. By supporting ISPOR and becoming an inaugural member of its Corporate Partnership Program, we are reaffirming our dedication to leveraging real-world evidence, market access, and HEOR transparently and ethically to ensure that healthcare decisions are guided by high-quality evidence,” said David W. Miller, CEO of Genesis Research Group. “We are delighted to join other industry leaders in taking an active role in shaping the future of HEOR.”

MEET GENESIS RESEARCH GROUP AT ISPOR 2025 IN MONTREAL!

Contact solutions@genesisrg.com.

This content was provided by Genesis Research Group

Company Details

 Latest Content from  Genesis Research Group 

Genesis Research and Clinical Outcomes Solutions announce innovative partnership

International Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) organization Genesis Research is delighted to announce an exciting new partnership with Clinical Outcomes Assessment (COA) specialist Clinical Outcomes...

Genesis Research Acquires Market Access Transformation

Genesis Research, a leading provider of tech-enabled Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) services, has entered into a definitive agreement to acquire Market Access Transformation (“MAT”),...

GHO Capital Acquires Genesis Research

GHO Capital Partners LLP, the European specialist investor in global healthcare, announces the acquisition of Genesis Research, a leading provider of tech-enabled Real-World Evidence (RWE) and Health Economics and Outcomes...

Genesis Research: What is EVID AI?

Genesis Research Announces Significant Enhancements to EVID AI, the World's Largest AI-Enabled Healthcare Literature Database for Faster, More Efficient Searches